Pharma

Your Article Summary

See Latest Articles

Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Amgen, 09/23/09

Amgen announced detailed results from a Phase 3, head–to–head trial evaluating denosumab versus Zometa(R) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. These results were presented during the Presidential Session at the 2009 ECCO 15 – ESMO 34 European Multidisciplinary Congress in Berlin, Germany.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

See All of Conferences/Meetings

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

See All of Drug Trials